EBON EBON
Company Profile ↓Company Overview
EBON (EBON) is a publicly traded company listed on with a market capitalization of $12.04M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $6.54M (+11.4% YoY); net profit $-14.09M.
- Trailing 12 Months Year-on-year growth — revenue +11.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -41.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -41.31% |
| 1 Year: | 11.39% |
Stock Price Performance
| 1 Year: | -55.58% |
| 6 Months: | -36.33% |
| 3 Months: | -20.00% |
| 1 Month: | -13.62% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)37.19 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -41.3% CAGR over 5 years.
- Trading 66.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 32.33M | 4.86M | 5.87M | 6.54M |
| Cost of Revenue | - | 16.92M | 21.56M | 4.68M | 6.14M |
| Gross Profit | - | 15.41M | -16.70M | 1.19M | 394.85K |
| Operating Expenses | - | 42.59M | 30.87M | 31.51M | 23.23M |
| Operating Income | - | -27.17M | -47.58M | -30.32M | -22.84M |
| EBITDA | - | -16.46M | -44.06M | -27.72M | -20.28M |
| Interest Expense | 4.38K | 0 | 0 | - | - |
| Pretax Income | - | -45.83M | -39.07M | -20.91M | -14.49M |
| Tax Provision | - | -72.93K | -1.03M | -42.55K | -320.98K |
| Net Income | - | -43.89M | -36.77M | -20.25M | -14.09M |
| Diluted EPS | - | -7.03 | -5.86 | -3.22 | -2.24 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 344.17M | 298.24M | 275.80M | 256.77M |
| Current Assets | - | 269.11M | 249.56M | 230.77M | 216.19M |
| Cash & Equivalents | - | 251.29M | 241.63M | 213.82M | 200.19M |
| Inventory | - | 440.06K | 198.85K | 597.12K | 3.64M |
| Receivables | - | 3.33M | 946.51K | 1.59M | 1.10M |
| Total Liabilities | - | 22.38M | 16.92M | 15.44M | 11.73M |
| Current Liabilities | - | 15.49M | 11.96M | 11.85M | 7.91M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 7.26M | 6.68M | 4.03M | 4.61M |
| Total Equity | - | 318.93M | 279.84M | 259.59M | 244.23M |
| Shares Outstanding | - | 6.26M | 6.28M | 6.54M | 6.54M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 5.15M | -11.53M | -17.61M | -9.05M |
| Investing Cash Flow | - | 5.75M | 2.63M | -9.89M | -5.37M |
| Financing Cash Flow | 248.28M | 0 | 0 | - | - |
| Capital Expenditure | - | -14.92M | -10.27M | -4.94M | -4.50M |
| Free Cash Flow | - | -9.77M | -21.80M | -22.55M | -13.54M |
| Net Change in Cash | - | 10.91M | -8.90M | -27.51M | -14.41M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 47.7% | -344.0% | 20.3% | 6.0% |
| Operating Margin % | - | -84.1% | -979.9% | -516.6% | -349.3% |
| Net Margin % | - | -135.8% | -757.4% | -345.1% | -215.6% |
| ROE % | - | -13.8% | -13.1% | -7.8% | -5.8% |
| ROCE % | - | -8.3% | -16.6% | -11.5% | -9.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for EBON
Marvell Stock Has Been Cut in Half. Its Biggest Fear May No Longer Be Valid.
Marvell’s recent selloff has been driven more by valuation than fundamentals, while one of its biggest long-standing risks appears to be fading.
SHG vs. EBKDY: Which Stock Is the Better Value Option?
SHG vs. EBKDY: Which Stock Is the Better Value Option?
Sandisk: What the Chart Is Trying to Tell Us
SanDisk stock has fallen about 40% from its June peak, breaking key $1,500 support amid an analyst downgrade and SK Hynix IPO volatility ahead of its August 5 earnings report.
Broadcom Declines on Erste Group’s Downgrade. Ignore the Noise and Keep Buying AVGO Stock.
One analyst believes that all of the optimism around Broadcom is priced into AVGO stock.
Erste Group Moves Broadcom (AVGO) to Hold
Broadcom Inc. (NASDAQ:AVGO) is one of the 15 Best NASDAQ 100 Stocks to Buy Other Than SpaceX. On July 7, 2026, Erste Group analyst Hans Engel downgraded Broadcom Inc. (NASDAQ:AVGO) to Hold from Buy previously. Engel said both gross margin a…
Top Bank Upgrades Meta Stock on Massive AI Spending Bet
Analyst Sees More Upside for Meta Stock After AI Spending Boost
EBON — Frequently Asked Questions
What is the current share price of EBON?
As of 2026-08-05 17:25 PDT, EBON trades at $1.84 on NASDAQ/NYSE. Its 52-week range is $1.72 to $5.42.
What is the market capitalisation of EBON?
EBON has a market capitalisation of $12.04M on NASDAQ/NYSE.
What is the P/E ratio of EBON?
EBON trades at a trailing price-to-earnings (P/E) ratio of -0.82. Its price-to-book (P/B) ratio is 0.05.
What is the return on equity (ROE) of EBON?
EBON has a return on equity (ROE) of -5.77%. Its return on capital employed (ROCE) is -9.18%.
Is EBON a good stock to buy?
This page provides a data-driven analysis of EBON, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.